Literature DB >> 2511135

High levels of acetaldehyde in nonalcoholic liver injury after threonine or ethanol administration.

X L Ma1, E Baraona, R Hernández-Muñoz, C S Lieber.   

Abstract

Acetaldehyde, a product of ethanol oxidation which forms adducts with proteins, has been incriminated in the pathogenesis of alcoholic liver injury. High serum antibody titers against acetaldehyde-protein adducts have been found not only in alcoholics but also in patients with nonalcoholic liver disease, suggesting a contribution of acetaldehyde derived from sources other than exogenous ethanol. To investigate the effect of liver injury on the removal and the production of acetaldehyde, we produced fibrosis and cirrhosis (by chronic administration of carbon tetrachloride) and fatty liver (with very small doses of dimethylnitrosamine) in rats. Endogenous blood acetaldehyde levels increased by 38% in rats with severe liver injury (p less than 0.005), but not significantly in rats with fatty liver. However, an i.v. load of threonine (a physiological source of acetaldehyde), in amounts equivalent to the daily intake of this amino acid, increased blood and hepatic acetaldehyde levels in the rats with both types of liver injury more than in controls. Threonine dehydrogenase and dehydratase activities, involved in the major pathways for threonine degradation in mitochondria and cytosol, respectively, were markedly decreased in rats with liver injury with a resulting increase in hepatic threonine concentration. Moreover, the threonine aldolase activity, which splits threonine into glycine and acetaldehyde, remained unaffected or even slightly increased. Liver injury was also associated with impaired mitochondrial functions, including a 10 to 23% decrease in acetaldehyde oxidation (depending upon the severity of the lesions). As a consequence, administration of ethanol (an exogenous source of acetaldehyde) resulted in striking elevations in the levels of acetaldehyde in carbon tetrachloride-treated rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2511135     DOI: 10.1002/hep.1840100607

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Role of aldehydes in fructose induced hypertension.

Authors:  S Vasdev; C A Ford; L Longerich; V Gadag; S Wadhawan
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

2.  Enhancement of camptothecin-induced topoisomerase I cleavage complexes by the acetaldehyde adduct N2-ethyl-2'-deoxyguanosine.

Authors:  Smitha Antony; Jacob A Theruvathu; P J Brooks; Diem-Thu Lesher; Matt Redinbo; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2004-10-21       Impact factor: 16.971

3.  Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption.

Authors:  O Niemelä; T Juvonen; S Parkkila
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis.

Authors:  Michael J Duryee; Lynell W Klassen; Courtney S Schaffert; Dean J Tuma; Carlos D Hunter; Robert P Garvin; Daniel R Anderson; Geoffrey M Thiele
Journal:  Free Radic Biol Med       Date:  2010-08-06       Impact factor: 7.376

5.  Mice have a transcribed L-threonine aldolase/GLY1 gene, but the human GLY1 gene is a non-processed pseudogene.

Authors:  Alasdair J Edgar
Journal:  BMC Genomics       Date:  2005-03-09       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.